APDM was founded with the objective of creating novel technologies to

  1. enable the scientific community to conduct quality research in movement science,
  2. accelerate clinical trials by introducing a new generation of biomarkers and validated endpoints, and
  3. improve the quality of life of people with movement disorders through precision medicine for neurodegenerative diseases.

FOUNDED 2007

Longest tenured team in wearable movement science industry

1,000+ CLIENTS

Researchers globally utilizing APDM technology

350+ PUBLICATIONS

Gold standard technology for precision motion analytics

10+ PATENTS

Portfolio with core/foundational patents (sensors, systems, & methods)

100+ OUTCOMES

Validated outcomes/endpoints ready for use in your study

45,000+ CITATIONS

World-class scholars in motion science, movement disorders, and biomedical signal processing

Matthew Johnson
Matthew Johnson
General Manager, Executive Officer
Mahmoud El-Gohary
Mahmoud El-Gohary
EVP Engineering, Executive Officer
Brent Casady
Brent Casady
EVP Operations, Executive Officer
Lars Holmstrom
Lars Holmstrom
AVP of Software Engineering
Andrew Greenberg
Andrew Greenberg
Principal Hardware Engineer
Fay Horak, PT, PhD
Fay Horak, PT, PhD
Scientific Fellow*
Mateo Aboy, PhD, MBA, CLP
Mateo Aboy, PhD, MBA, CLP
Scientific Fellow*
James McNames, PhD
James McNames, PhD
Scientific Fellow*

* The title of APDM Fellow is the company’s pre-eminent technical & research distinction. It is the highest level of scientific/technical achievement and it is granted in recognition of outstanding foundational contributions to APDM combined with a sustained record of scholarly leadership demonstrated by research, invention, and scholarly publications at the highest levels of international excellence

COMPANY HISTORY

APDM’s platform has been validated by the top world researchers for over 10 years and has hundreds of scientific publications and studies validating the technology and outcome measures.